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ObjeCtives: The present study analyses the impact and influence of negative 
symptoms on quality of life (QoL). MethOds: The W-SOHO study is a three year 
follow-up study on the outpatient care of schizophrenia that included 17,384 
patients from 37 countries. Patients were recruited in W-SOHO by their treating 
psychiatrists when starting or changing antipsychotic medication. Evaluation 
was conducted during the normal course of care and was scheduled every six 
months after the baseline visit. The Clinical Global Impressions Severity Scale 
– Schizophrenia version (CGI-SCH) was used to assess symptom severity across 
overall, positive, negative, depressive and cognitive subdomains. Quality of life 
(QoL) was assessed using the EuroQOL 5-D questionnaire. Pearson correlation 
coefficients (PCC) were used to analyze the relationship between continuous vari-
ables. A mixed model with repeated measures (MMRM) was used to analyze the 
factors associated with quality of life during follow-up. Results: Quality of life at 
baseline was more highly correlated with negative symptoms than with positive 
symptoms (PCC -0.25 for positive symptoms and -0.29 for negative symptoms; 
p< 0.001). Improvement in negative symptoms was highly correlated to improve-
ment in QoL (PCC 0.33; p< 0.0001). The regression model analysing the influence 
of both positive and negative symptoms on QoL at baseline was confirmative and 
showed a greater beta coefficient (higher influence) for negative symptoms com-
pared with positive symptoms [(3.9 (se 0.14) versus 2.9 (se 0.13)]. Another model 
found that patients with greater negative symptoms at baseline experienced lower 
improvement in QoL (beta coefficient -0.81; se 0.11; p< 0.001). COnClusiOns: In 
patients with schizophrenia negative symptoms seem to have a larger influence 
onself-perceived QoL than positive symptoms. Improvement in negative symp-
toms is highly associated with improvements in QoL.
